Rifampcin-induced Thrombocytopaenia Purpura
Hamed Bashir, Shahid Mahdi, Alok Anand
The Indian Journal of Chest Diseases and Allied Sciences · 2022-11
Abstract
We report the case of a 28-year-old resident doctor with no past history of having taken rifampicin, who presented with thrombocytoapaenic purpura occurring after the initiation of anti-tuberculosis therapy (isoniazid, rifampicin, pyrazinamide and ethambutol) for tubercular lymphadenopathy.
MeSH terms
- Medicine
- Rifampicin
- Pyrazinamide
- Ethambutol
- Isoniazid
- Tuberculosis
- Purpura (gastropod)
- Dermatology
- Surgery
- Internal medicine